VERAPTUS® aptamers were selected against HER2 positive breast cancer cell lines. Validating experiments show the VERAPTUS® aptamer binds to the HER2 receptor. HER2 is a clinically relevant marker for diagnostic and therapeutic applications for certain types of breast cancer.
Purification: >1 mg of 50-80 base pair desalted DNA
There are no reviews yet.